Prescription drug · ANDA
ondansetron hydrochloride NDC 55111-155
Ondansetron hydrochloride 16 mg/1 · Tablet, Film coated · Oral · Dr. Reddy's Laboratories Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55111-155-05 | 55111015505 | 500 TABLET, FILM COATED in 1 BOTTLE (55111-155-05)Marketed from Dec 26, 2006 | |
| 55111-155-30 | 55111015530 | 30 TABLET, FILM COATED in 1 BOTTLE (55111-155-30)Marketed from Dec 26, 2006 | |
| 55111-155-78 | 55111015578 | 10 BLISTER PACK in 1 CARTON (55111-155-78) / 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-155-79)Marketed from Dec 26, 2006 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- ondansetron hydrochloride
- Generic name (nonproprietary)
- ondansetron hydrochloride
- Active ingredients
- Ondansetron hydrochloride — 16 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 076183
- Marketing start
- Listing expires
- Other FDA classes
- Serotonin 3 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 55111-155_9064dccd-0ae4-688a-3216-6ced5e514340SPL ID 9064dccd-0ae4-688a-3216-6ced5e514340SPL set ID 476e704c-95ae-4591-94f7-ee4ab827ff13RxCUI 692695UNII NMH84OZK2B
- Pharmacologic class
- Serotonin-3 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N455111015505followed by a unit qualifier and the quantityPackage 55111-0155-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Ondansetron tablets are indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m 2 . initial and repeat courses of moderately emetogenic cancer chemotherapy. radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen Ondansetron tablets are also indicated for the prevention of postoperative nausea and/or vomiting. Ondansetron tablets are 5-HT 3 receptor antagonist indicated for the prevention of: nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin greater than or eq…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 076183
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| ondansetronondansetron hydrochloride | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-3551 |
| Ondansetronondansetron hydrochloride | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Limited | 55111-153 |
| Ondansetronondansetron hydrochloride | Ondansetron hydrochloride 8 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Limited | 55111-154 |
| Ondansetronondansetron hydrochloride | Ondansetron hydrochloride 24 mg/1 | Tablet, Film coatedOral | Dr. Reddy's Laboratories Limited | 55111-156 |
| Ondansetron | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | HF Acquisition Co LLC, DBA HealthFirst | 51662-1539 |
| Ondansetron | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | HF Acquisition Co LLC, DBA HealthFirst | 51662-1678 |
| ondansetronondansetron hydrochloride | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-6551 |
| ondansetronondansetron hydrochloride | Ondansetron hydrochloride 8 mg/1 | Tablet, Film coatedOral | Major Pharmaceuticals | 0904-6552 |
| ondansetron hydrochloride | Ondansetron hydrochloride 4 mg/1 | Tablet, Film coatedOral | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8185 |
| ondansetronondansetron hydrochloride | Ondansetron hydrochloride 8 mg/1 | Tablet, Film coatedOral | Cardinal Health 107, LLC | 55154-7879 |